Loading…

267 DERMATOLOGIC ADVERSE EVENTS WITHIN THE FIRST 60 DAYS OF SORAFENIB TREATMENT ARE ASSOCIATED WITH BETTER OVERALL SURVIVAL (OS) IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC)

Saved in:

Bibliographic Details
Published in:	Journal of hepatology 2013-04, Vol.58, p.S113-S113
Main Authors:	Reig, M, Rodriguez de Lope, C, Llarch, N, Forner, A, Torres, F, Rios, J, Boix, L, Rimola, J, Darnell, A, Ayuso, C, Bruix, J
Format:	Article
Language:	English
Subjects:	Gastroenterology and Hepatology
Citations:	Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!